510(k) K202525
K202525 is an FDA 510(k) premarket notification submitted by Abbott Laboratories Diagnostics Division for the device "Alinity i STAT High Sensitivity Troponin-I". The FDA issued a decision of Substantially Equivalent on May 19, 2022. The device falls under product code MMI (Immunoassay Method, Troponin Subunit), a Class II device regulated under 21 CFR 862.1215. Abbott Laboratories Diagnostics Division has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 19, 2022
- Date Received
- September 1, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Immunoassay Method, Troponin Subunit
- Device Class
- Class II
- Regulation Number
- 862.1215
- Review Panel
- CH
- Submission Type